Heska sells veterinary and animal health diagnostic and specialty products. Co.'s primary focus is on the canine and feline healthcare space. Co.'s business is composed of two segments: North America and International. Co.'s major product categories sold in both segments include: Point of Care laboratory instruments and consumables; digital imaging diagnostic instruments, software and services; digital cytology services; local and cloud-based data services; allergy testing and immunotherapy; and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production. The HSKA stock yearly return is shown above.
The yearly return on the HSKA stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the HSKA annual return calculation with any dividends reinvested as applicable (on ex-dates).
|